The takeaway
Axogen Inc shows a moderate seasonal pattern over 10 years of data — strongest in February (+5.6%) and softest in January (+0.5%).
Right now
In July, the stock has risen 30% of years, averaging +1.0%, roughly 1.2 pts behind the S&P 500.
The full picture
Axogen Inc's most dependable month has been February, higher in 7 of 10 years; January has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in November (+9.8 pts); it has trailed the market most in March (−3.7 pts).
“vs S&P” is Axogen Inc’s average for a month minus the S&P 500’s average for that same month — isolating Axogen Inc’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, February has closed higher 80% of the time versus 70% across the last 10 years — the pattern is strengthening.
Figures are the typical (median) February return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
This is a stock you can almost set a calendar by, and February is the anchor — it has closed higher in 7 of 10 Februaries, the steadiest beat on its year.
The strength looks broad-based rather than freakish: its average (+5.6%) and median (+6.2%) sit close together, so no single blow-out year is flattering the figure. Few months are steadier: February's returns vary by just 9.6% year to year. Better still, that strength is the stock's own and not just a buoyant market — February has outpaced the S&P 500 by +5.9 points on average. It is the more striking for the company it keeps — February is a losing month for most of the market, where barely 49% of names gain ground.
It doesn't stand entirely alone — June and December have leaned firm as well, if less emphatically. On the other side of the ledger, January is the year's quietest corner, essentially flat on average, and the edge isn't year-round — the stock has trailed the S&P 500 in March, September, and July. Its roughest month on record was a −40.4% December in 2018 — a reminder of how hard even a seasonal name can fall.
If anything it has sharpened recently — the last five Februaries run ahead of the earlier years.
For a stock this dependable in February, the sharper question is the rest of the year — outside its strong stretch, the calendar gives far less to lean on. With returns that swing hard year to year, the signal is best held loosely.
Short answers on the stock's best month (February), its worst (January), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2016 its best month (February, +5.6%) has run well ahead of its worst (January, +0.5%) — the heatmap above shows how steady that gap has been year to year.
February has been the strongest, averaging +5.6% and closing higher in 7 of 10 years since 2016.
It's the weakest month, but it has still averaged a small gain (+0.5%) — quiet rather than genuinely bad.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade